How India Can Lead Global Pharma | ENTOD's Journey & Vision with Masurkar

In this inspiring episode of The Sound of Money, host Santosh Sirur dives deep into the remarkable journey of the Masurkar family and the phenomenal growth of ENTOD Pharmaceuticals — a company that has been redefining Indian pharma since 1977.From a bold entrepreneurial start to becoming a leader in ophthalmology, ENT, and dermatological innovations, ENTOD represents more than just business success — it's a vision rooted in science, spirituality, excellence, and accessibility.What you’ll learn in this episode:The legacy, values, and vision behind ENTOD’s rise from 1977 to 2025How maverick leadership is steering the company from a volume-driven to a value-driven research ecosystem, especially in the MSME sectorThe company’s indigenous breakthroughs and commitment to research-driven innovationWhy Indian pharma is poised to lead the Global South and emerging marketsInsights on how India can build a $450B pharma industry by 2047 alignedwith the Viksit Bharat visionThe need for a India-centric approach rather than dependence on US marketsThoughts on the potential impact of US tariffs and how Indian pharma cannavigate global headwindsA deep reflection on how Indian excellence fused with global thinking andspiritual depth can shape the future of healthcareWhether you're a healthcare professional, policy maker, investor, or simply curious about the future of Indian pharma, this episode offers valuable insights into building a globally competitive yet soulfully rooted healthcare industry.👉 Don’t forget to like, comment, and subscribe for more transformativeConversations on The Sound of Money.